Chima Ohadugha
Hospitalist · Thomasville, NCNPI 1831621853
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $477 of the $577 with a category attached, or 82.7%. 11 manufacturers reported payments, led by Boehringer Ingelheim at 27.6% of the total. Reporting peaked in 2022 at $173 and has fallen 85.0% since, to $26 in 2025.
Across 17 payments — averaging $33.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$159
- Genentech USA, Inc.$100
- Lantheus Medical Imaging, Inc.$82
- Boston Scientific$62
- E.r. Squibb & Sons, L.L.C.$60
- Johnson & Johnson$24
- plus $90 from 5 others
What the payments were for
- Food & beverage$47783%
- Education$10017%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 5 | $159 |
| Genentech USA, Inc. | 1 | $100 |
| Lantheus Medical Imaging, Inc. | 1 | $82 |
| Boston Scientific | 1 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Johnson & Johnson | 1 | $24 |
| Amgen | 1 | $23 |
| Pfizer | 1 | $19 |
| Novartis | 1 | $17 |
| Merck | 1 | $16 |
| AstraZeneca | 1 | $15 |
How this compares
$577 in reported general payments places this provider in the 70th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 30 | $203 |
| Atorvastatin Calcium | 15 | $93 |
| Valsartan | 11 | $90 |
| Doxycycline Hyclate | 16 | $83 |
| Oxycodone Hcl | 16 | $59 |
| Metoprolol Succinate | 11 | $27 |
| Prednisone | 24 | $26 |
| Amlodipine Besylate | 15 | $19 |
| Furosemide | 17 | $15 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Thomasville
- Mahesh ChandrasekharWinston Salem$86K
- Dwan VarnerGreenville$59K
- Honnie SpencerSalisbury$50K
- Ria DancelChapel Hill$13K
- Javad MonzavifarCharlotte$12K
- Bikki GautamCharlotte$12K
- Jorge PaulinoCharlotte$12K
- Emmett StewardCharlotte$11K
- Stephan HewittGastonia$11K
- Juan Velasco-TrujilloMatthews$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.